Reversing diabetes with CRISPR and patient-derived stem cells

Reversing diabetes with CRISPR and patient-derived stem cells

Source: 
Fierce Biotech
snippet: 

Now, scientists at Washington University in St. Louis have developed a way to use gene editing system CRISPR-Cas9 to edit a mutation in human-induced pluripotent stem cells (iPSCs) and then turn them into beta cells. When transplanted into mice, the cells reversed preexisting diabetes in a lasting way, according to results published in the journal Science Translational Medicine.